Free Trial

Onto Innovation (ONTO) Financials

Onto Innovation logo
$277.12 -0.82 (-0.30%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$279.50 +2.38 (+0.86%)
As of 05/13/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Onto Innovation

Annual Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/27/2014 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024
Net Income / (Loss) Attributable to Common Shareholders
-31 2.91 44 33 45 1.91 31 142 223 121 202
Consolidated Net Income / (Loss)
-31 2.91 44 33 45 1.91 31 142 223 121 202
Net Income / (Loss) Continuing Operations
-31 2.91 44 33 45 1.91 31 142 223 121 202
Total Pre-Tax Income
-12 5.57 29 60 53 -0.60 -27 156 242 133 220
Total Operating Income
-12 4.97 29 59 51 -5.04 -27 156 237 116 187
Total Gross Profit
76 90 114 135 148 135 278 429 539 420 515
Total Revenue
166 187 221 255 274 306 556 789 1,005 816 987
Operating Revenue
166 187 221 255 274 306 556 789 1,005 816 987
Total Cost of Revenue
91 98 107 121 126 171 278 360 466 396 472
Operating Cost of Revenue
91 98 107 121 126 171 278 360 466 396 472
Total Operating Expenses
87 85 85 75 97 140 252 273 303 304 328
Selling, General & Admin Expense
24 22 23 28 34 53 65 68 70 80 80
Marketing Expense
27 28 30 21 22 28 48 57 66 62 76
Research & Development Expense
34 33 31 38 40 48 85 96 112 104 114
Amortization Expense
0.42 0.11 0.02 1.94 1.53 10 54 51 55 55 49
Other Operating Expenses / (Income)
- - - - - - - - - 3.57 9.01
Total Other Income / (Expense), net
0.03 0.60 0.04 0.51 2.26 4.45 0.19 -0.73 4.87 17 33
Interest & Investment Income
0.05 0.07 0.04 0.97 2.21 3.67 2.90 1.16 5.01 20 33
Other Income / (Expense), net
0.37 0.81 0.29 -0.46 0.06 0.78 -2.71 -1.89 -0.14 -3.85 -0.15
Income Tax Expense
19 2.66 -15 27 8.25 -2.51 -4.16 13 18 11 19
Basic Earnings per Share
($1.30) $0.12 $1.79 $1.30 $1.77 $0.06 $0.63 $2.89 $4.52 $2.47 $4.09
Weighted Average Basic Shares Outstanding
23.96M 24.06M 24.66M 25.33M 25.47M 29.73M 49.14M 49.24M 49.42M 48.97M 49.34M
Diluted Earnings per Share
($1.30) $0.12 $1.75 $1.27 $1.74 $0.06 $0.63 $2.86 $4.49 $2.46 $4.06
Weighted Average Diluted Shares Outstanding
23.96M 24.38M 25.15M 25.87M 25.90M 30.01M 49.48M 49.73M 49.76M 49.32M 49.66M
Weighted Average Basic & Diluted Shares Outstanding
23.90M 24.20M 24.60M 25.40M 24.10M 50.28M 48.88M 49.36M 48.75M 49.13M 49.70M

Quarterly Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
26 36 30 47 53 53 49 64 34 28 34
Consolidated Net Income / (Loss)
26 36 30 47 53 53 49 64 34 28 34
Net Income / (Loss) Continuing Operations
26 36 30 47 53 53 49 64 34 28 34
Total Pre-Tax Income
28 39 34 51 57 61 51 72 40 32 38
Total Operating Income
25 34 28 43 49 53 42 63 32 24 34
Total Gross Profit
100 107 108 118 128 136 132 143 122 111 146
Total Revenue
191 207 219 229 242 252 264 267 254 218 292
Operating Revenue
191 207 219 229 242 252 264 267 254 218 292
Total Cost of Revenue
90 100 111 111 114 118 132 123 138 112 151
Operating Cost of Revenue
90 100 111 111 114 118 132 123 138 112 151
Total Operating Expenses
76 73 80 76 79 81 90 80 84 83 108
Selling, General & Admin Expense
19 18 27 18 20 20 26 23 25 25 31
Marketing Expense
16 15 15 18 19 19 19 20 15 17 21
Research & Development Expense
27 26 24 27 27 28 35 28 35 32 35
Amortization Expense
14 14 13 13 13 13 10 8.45 8.45 8.45 20
Total Other Income / (Expense), net
3.05 4.69 5.60 8.15 8.44 7.94 8.81 8.52 7.49 8.29 4.54
Interest & Investment Income
4.76 5.69 6.46 7.36 8.50 8.67 8.97 9.27 8.63 9.29 5.10
Other Income / (Expense), net
-1.71 -1.00 -0.86 0.79 -0.06 -0.72 -0.15 -0.74 -1.14 -1.00 -0.56
Income Tax Expense
1.96 2.81 3.52 4.04 4.32 7.96 2.45 7.56 5.83 3.76 4.30
Basic Earnings per Share
$0.53 $0.73 $0.61 $0.95 $1.07 $1.07 $1.00 $1.30 $0.69 $0.58 $0.68
Weighted Average Basic Shares Outstanding
48.98M 49.04M 48.97M 49.23M 49.34M 49.43M 49.34M 49.18M 48.93M 49.02M 49.74M
Diluted Earnings per Share
$0.53 $0.73 $0.61 $0.94 $1.07 $1.07 $0.98 $1.30 $0.69 $0.57 $0.67
Weighted Average Diluted Shares Outstanding
49.27M 49.40M 49.32M 49.64M 49.67M 49.69M 49.66M 49.41M 49.02M 49.11M 50.00M
Weighted Average Basic & Diluted Shares Outstanding
49.07M 49.08M 49.13M 49.28M 49.38M 49.39M 49.27M 48.87M 49.00M 49.01M 49.74M

Annual Cash Flow Statements for Onto Innovation

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/27/2014 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 1/3/2026
Net Change in Cash & Equivalents
-10 3.48 8.91 30 45 18 -52 33 24 58 133
Net Cash From Operating Activities
-0.64 1.57 46 64 35 18 106 175 137 172 328
Net Cash From Continuing Operating Activities
-0.64 1.57 46 64 35 18 50 175 148 172 328
Net Income / (Loss) Continuing Operations
-31 2.91 44 33 45 1.91 31 142 223 121 137
Consolidated Net Income / (Loss)
-31 2.91 44 33 45 1.91 31 142 223 121 137
Depreciation Expense
9.77 9.08 8.30 3.99 4.85 5.97 14 14 9.38 12 21
Amortization Expense
- - - 1.94 1.53 26 64 52 55 50 35
Non-Cash Adjustments To Reconcile Net Income
15 9.02 11 9.87 11 24 37 30 40 39 63
Changes in Operating Assets and Liabilities, net
5.63 -19 -17 15 -27 -39 -97 -63 -180 -50 73
Net Cash From Investing Activities
-8.05 1.95 -42 -33 34 4.10 49 -142 -56 -103 -122
Net Cash From Continuing Investing Activities
-8.05 1.95 -42 -33 34 4.10 -49 -142 -56 -103 -122
Purchase of Property, Plant & Equipment
-5.79 -1.85 -4.00 -10 -7.54 -6.80 -3.83 -12 -18 -23 -29
Acquisitions
- - 0.00 -1.00 - 0.00 0.00 -24 -4.64 0.00 -436
Purchase of Investments
-41 -41 -83 -165 -140 -127 -313 -361 -371 -480 -476
Sale of Property, Plant & Equipment
- - 0.00 - - - - 0.00 0.00 2.80 0.00
Sale and/or Maturity of Investments
39 45 45 143 186 94 265 255 339 397 827
Other Investing Activities, net
- - - 0.00 -5.00 0.00 2.85 - - 0.00 -8.00
Net Cash From Financing Activities
-0.68 0.22 5.27 -2.55 -24 -4.20 -54 2.67 -68 -9.48 -75
Net Cash From Continuing Financing Activities
-0.68 0.22 5.27 -2.55 -24 -4.20 -54 2.67 -68 -9.48 -75
Repurchase of Common Equity
-5.34 -1.72 0.00 -1.03 -21 -0.74 -52 0.00 -65 -3.20 -75
Issuance of Common Equity
5.96 3.97 8.45 0.62 0.62 0.84 2.92 10 8.07 5.29 13
Other Financing Activities, net
-0.70 -1.18 -2.86 -2.15 -3.46 -4.30 -4.62 -7.40 -11 -12 -14
Effect of Exchange Rate Changes
-0.73 -0.26 0.08 0.81 -0.34 0.23 - - - -1.48 1.58
Cash Income Taxes Paid
0.86 -0.83 3.77 15 4.30 -3.85 0.00 24 59 34 36

Quarterly Cash Flow Statements for Onto Innovation

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 3/31/2026
Net Change in Cash & Equivalents
-6.23 -18 51 -43 -18 16 24 -9.22 14 386 -94
Net Cash From Operating Activities
32 29 62 57 65 67 56 92 58 83 26
Net Cash From Continuing Operating Activities
29 29 84 57 65 67 56 92 58 83 26
Net Income / (Loss) Continuing Operations
26 36 30 47 53 53 49 64 34 28 34
Consolidated Net Income / (Loss)
26 36 30 47 53 53 49 64 34 28 34
Depreciation Expense
2.90 3.20 3.37 3.39 3.53 3.90 2.05 4.40 5.84 4.94 5.78
Amortization Expense
14 14 13 12 13 13 10 6.91 6.95 7.18 19
Non-Cash Adjustments To Reconcile Net Income
9.30 7.64 9.49 7.99 9.85 9.81 25 9.52 27 9.10 8.88
Changes in Operating Assets and Liabilities, net
-23 -32 28 -13 -14 -13 -30 7.06 -16 34 -42
Net Cash From Investing Activities
-9.66 -43 -37 -92 -74 -57 -4.10 -22 -43 297 -113
Net Cash From Continuing Investing Activities
-36 -43 -37 -92 -74 -57 -4.10 -22 -43 297 -113
Purchase of Property, Plant & Equipment
-4.61 -7.65 -2.46 -6.98 -12 -8.05 -4.63 -8.23 -14 -1.38 -3.59
Acquisitions
- - - 0.00 - - - -0.06 - - 0.00
Purchase of Investments
-121 -151 -120 -208 -187 -143 -171 -209 -211 -1.84 -180
Sale and/or Maturity of Investments
89 115 83 123 125 95 198 203 182 300 70
Other Investing Activities, net
- - - 0.00 - - - -8.00 - - 0.00
Net Cash From Financing Activities
1.31 -0.92 -0.39 -5.07 -8.87 3.95 -26 -80 -3.71 5.36 -6.70
Net Cash From Continuing Financing Activities
1.31 -0.92 -0.39 -5.07 -8.87 3.95 -26 -80 -3.71 5.36 -6.70
Repurchase of Common Equity
- - - 0.00 - - -25 -75 - - 0.00
Issuance of Common Equity
5.29 - - 4.02 -0.00 5.16 - 4.18 - 5.56 0.00
Other Financing Activities, net
-3.98 -0.92 -0.39 -9.09 -8.87 -1.22 -0.60 -8.68 -3.71 -0.20 -6.70
Effect of Exchange Rate Changes
- -2.03 - - - - -2.02 0.13 2.52 0.11 -0.89
Cash Income Taxes Paid
18 10 5.17 0.92 21 8.71 5.27 0.77 32 2.83 1.57

Annual Balance Sheets for Onto Innovation

This table presents Onto Innovation's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets
236 288 310 418 1,449 1,468 1,650 1,795 1,910 2,117 2,368
Total Current Assets
178 216 240 351 642 732 948 1,135 1,283 1,478 1,268
Cash & Equivalents
38 47 35 112 131 137 170 176 234 213 346
Short-Term Investments
45 83 82 63 190 237 342 372 464 639 294
Accounts Receivable
38 39 62 64 124 149 177 241 227 308 269
Inventories, net
51 41 54 97 176 191 243 324 328 287 298
Prepaid Expenses
6.59 5.67 6.23 15 22 17 16 21 31 30 61
Plant, Property, & Equipment, net
44 44 45 19 98 88 82 92 104 124 127
Total Noncurrent Assets
13 27 25 48 708 649 620 568 523 516 973
Goodwill
9.42 8.94 10 22 307 307 316 316 316 330 644
Intangible Assets
1.87 0.41 2.21 7.45 372 318 277 222 167 127 298
Noncurrent Deferred & Refundable Income Taxes
1.12 17 12 13 1.46 2.24 4.82 4.78 19 43 3.86
Other Noncurrent Operating Assets
0.53 0.47 0.41 5.51 28 21 22 25 21 15 27
Total Liabilities & Shareholders' Equity
236 288 310 418 1,449 1,468 1,650 1,795 1,910 2,117 2,368
Total Liabilities
48 44 47 56 185 203 224 198 173 191 267
Total Current Liabilities
45 42 44 45 86 120 155 161 148 170 219
Accounts Payable
12 11 14 17 28 40 53 55 50 56 108
Accrued Expenses
- - - 14 26 37 43 49 42 50 49
Current Deferred Revenue
13 9.17 7.41 6.77 13 14 30 30 25 34 32
Other Current Liabilities
8.88 8.05 7.25 7.54 19 28 28 27 31 30 31
Total Noncurrent Liabilities
3.00 2.03 3.22 11 99 83 69 38 25 21 48
Noncurrent Deferred & Payable Income Tax Liabilities
0.52 0.02 0.18 0.00 67 56 40 7.37 0.00 0.00 20
Other Noncurrent Operating Liabilities
0.88 0.35 0.52 11 32 28 29 31 25 21 28
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Preferred & Common Equity
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Common Equity
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Common Stock
259 272 255 370 1,269 1,234 1,256 1,244 1,262 1,275 1,367
Retained Earnings
-66 -22 9.11 -6.77 -4.86 26 169 363 482 665 744
Accumulated Other Comprehensive Income / (Loss)
-5.20 -6.05 -2.12 -1.26 -0.60 4.57 1.32 -10 -7.90 -14 -10

Quarterly Balance Sheets for Onto Innovation

This table presents Onto Innovation's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/1/2022 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 3/31/2026
Total Assets
1,788 1,803 1,821 1,862 1,953 2,005 2,073 2,115 2,140 2,187 2,396
Total Current Assets
1,123 1,155 1,183 1,221 1,333 1,385 1,458 1,469 1,494 1,545 1,320
Cash & Equivalents
200 230 224 207 191 173 189 204 217 603 252
Short-Term Investments
352 353 385 423 550 613 667 647 677 381 402
Accounts Receivable
236 210 188 210 232 238 254 292 285 260 307
Inventories, net
308 338 352 346 330 320 308 293 270 259 316
Prepaid Expenses
27 24 34 36 31 42 41 34 44 41 43
Plant, Property, & Equipment, net
84 98 100 104 107 115 120 127 133 129 124
Total Noncurrent Assets
581 550 538 537 514 505 495 519 513 513 953
Goodwill
316 316 316 316 316 316 316 330 330 330 643
Intangible Assets
236 208 195 181 154 141 128 119 111 102 278
Noncurrent Deferred & Refundable Income Taxes
4.29 4.79 8.32 18 24 29 35 47 50 57 4.45
Other Noncurrent Operating Assets
25 21 19 22 19 18 17 23 22 23 27
Total Liabilities & Shareholders' Equity
1,788 1,803 1,821 1,862 1,953 2,005 2,073 2,115 2,140 2,187 2,396
Total Liabilities
218 178 164 166 172 174 170 195 177 185 264
Total Current Liabilities
170 148 137 136 147 148 145 174 156 163 214
Accounts Payable
64 54 50 44 56 51 48 55 38 53 106
Accrued Expenses
45 38 36 39 35 40 44 42 50 49 46
Current Deferred Revenue
29 28 24 23 26 28 27 39 39 31 31
Other Current Liabilities
31 29 27 29 30 28 26 38 29 30 31
Total Noncurrent Liabilities
49 30 27 30 25 25 25 21 21 22 50
Noncurrent Deferred & Payable Income Tax Liabilities
16 1.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20
Other Noncurrent Operating Liabilities
33 28 27 30 25 25 25 21 21 22 29
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,569 1,625 1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132
Total Preferred & Common Equity
1,569 1,625 1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132
Total Common Equity
1,569 1,625 1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132
Common Stock
1,260 1,242 1,251 1,257 1,263 1,263 1,275 1,260 1,263 1,275 1,367
Retained Earnings
326 390 416 452 529 582 635 671 705 733 778
Accumulated Other Comprehensive Income / (Loss)
-16 -7.53 -11 -13 -11 -13 -6.33 -12 -4.75 -6.42 -13

Annual Metrics And Ratios for Onto Innovation

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/27/2014 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
15.34% 12.57% 18.02% 15.36% 7.33% 11.73% 81.92% 41.76% 27.42% -18.83% 21.01%
EBITDA Growth
89.34% 1,082.87% 153.55% 71.87% -11.18% -52.16% 77.60% 351.62% 36.48% -40.43% 38.92%
EBIT Growth
50.91% 151.30% 407.86% 100.21% -13.07% -108.34% -589.30% 625.84% 53.10% -52.56% 66.59%
NOPAT Growth
46.32% 131.81% 1,594.87% -25.81% 32.36% -108.17% -428.99% 865.84% 53.02% -51.53% 61.36%
Net Income Growth
-119.98% 109.34% 1,415.83% -25.27% 37.03% -95.76% 1,524.35% 358.82% 56.89% -45.75% 66.45%
EPS Growth
-113.11% 109.23% 1,358.33% -27.43% 37.01% -96.55% 950.00% 353.97% 56.99% -45.21% 65.04%
Operating Cash Flow Growth
73.88% 347.40% 2,808.02% 40.46% -45.31% -48.29% 484.06% 65.38% -22.01% 25.80% 42.86%
Free Cash Flow Firm Growth
158.13% -156.35% 666.48% -96.85% 58.67% -44,268.62% 104.48% 250.00% -28.85% 36.62% 17.54%
Invested Capital Growth
-16.54% 9.07% 9.18% 27.71% 28.52% 405.20% -5.59% 2.66% 14.64% -0.95% 3.35%
Revenue Q/Q Growth
-3.73% 1.62% 8.05% 6.48% -15.02% 44.55% 6.62% 9.82% 2.83% -4.05% 4.78%
EBITDA Q/Q Growth
-136.60% 33.37% 34.99% 60.93% -39.27% 57.65% -34.65% 67.74% 4.26% -16.41% 4.34%
EBIT Q/Q Growth
-66.36% 80.25% 52.85% 77.38% -43.79% -130.08% -117.36% 136.12% 5.96% -24.15% 8.68%
NOPAT Q/Q Growth
-77.77% 4,256.71% 180.41% -28.13% -26.55% -125.82% -134.15% 126.37% 7.69% -25.55% 9.74%
Net Income Q/Q Growth
-20.04% 3,577.22% 182.86% -28.55% -23.73% -90.02% 567.17% 23.22% 9.55% -22.86% 10.10%
EPS Q/Q Growth
-21.50% 0.00% 186.89% -29.83% -26.89% -90.91% 226.00% 22.22% 10.05% -22.88% 10.03%
Operating Cash Flow Q/Q Growth
92.13% -86.05% 37.09% 137.95% -73.45% 177.50% 60.33% 9.96% 0.36% 7.56% -2.22%
Free Cash Flow Firm Q/Q Growth
1,321.08% -347.74% 65.86% -88.43% -97.60% -1,087.42% 104.83% 146.24% -13.84% 25.17% -21.80%
Invested Capital Q/Q Growth
-9.46% 1.04% 16.00% 8.37% 54.22% 374.61% -0.70% 0.30% 3.15% -2.60% 2.43%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
45.55% 47.86% 51.61% 52.76% 54.16% 44.14% 50.04% 54.39% 53.64% 51.51% 52.19%
EBITDA Margin
-0.91% 7.93% 17.04% 25.39% 21.01% 9.00% 8.78% 27.98% 29.97% 21.99% 25.25%
Operating Margin
-7.00% 2.65% 13.16% 23.24% 18.66% -1.65% -4.79% 19.83% 23.55% 14.23% 18.95%
EBIT Margin
-6.78% 3.09% 13.29% 23.06% 18.68% -1.39% -5.28% 19.59% 23.54% 13.76% 18.94%
Profit (Net Income) Margin
-18.70% 1.55% 19.91% 12.90% 16.47% 0.62% 5.58% 18.04% 22.22% 14.85% 20.43%
Tax Burden Percent
267.77% 52.17% 151.14% 55.03% 84.53% -319.93% -115.47% 91.44% 92.45% 91.38% 91.48%
Interest Burden Percent
103.03% 96.23% 99.15% 101.65% 104.31% 14.00% 91.43% 100.75% 102.12% 118.14% 117.91%
Effective Tax Rate
0.00% 47.83% -51.14% 44.97% 15.47% 0.00% 0.00% 8.56% 7.55% 8.62% 8.52%
Return on Invested Capital (ROIC)
-7.77% 2.60% 40.33% 25.18% 26.00% -0.62% -2.04% 15.84% 22.29% 10.16% 16.21%
ROIC Less NNEP Spread (ROIC-NNEP)
18.20% 2.23% 40.28% 24.95% 24.69% -2.82% -16.36% 15.99% 21.44% 7.74% 12.27%
Return on Net Nonoperating Assets (RNNOA)
-8.32% -1.01% -19.90% -12.17% -11.55% 0.86% 4.49% -5.26% -7.51% -2.89% -5.19%
Return on Equity (ROE)
-16.09% 1.58% 20.43% 13.00% 14.45% 0.23% 2.45% 10.58% 14.78% 7.27% 11.01%
Cash Return on Invested Capital (CROIC)
10.26% -6.08% 31.56% 0.84% 1.04% -134.53% 3.72% 13.22% 8.65% 11.11% 12.91%
Operating Return on Assets (OROA)
-4.64% 2.52% 11.23% 19.69% 14.05% -0.46% -2.01% 9.91% 13.74% 6.06% 9.29%
Return on Assets (ROA)
-12.80% 1.27% 16.83% 11.02% 12.39% 0.20% 2.13% 9.13% 12.97% 6.54% 10.02%
Return on Common Equity (ROCE)
-16.09% 1.58% 20.43% 13.00% 14.45% 0.23% 2.45% 10.58% 14.78% 7.27% 11.01%
Return on Equity Simple (ROE_SIMPLE)
-17.33% 1.55% 18.06% 12.54% 12.46% 0.15% 2.45% 9.98% 13.99% 6.98% 10.47%
Net Operating Profit after Tax (NOPAT)
-8.16 2.59 44 33 43 -3.53 -19 143 219 106 171
NOPAT Margin
-4.90% 1.38% 19.89% 12.79% 15.77% -1.15% -3.36% 18.13% 21.77% 13.00% 17.34%
Net Nonoperating Expense Percent (NNEP)
-25.97% 0.37% 0.06% 0.23% 1.31% 2.20% 14.32% -0.15% 0.85% 2.42% 3.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 13.71% 6.11% 8.89%
Cost of Revenue to Revenue
54.45% 52.14% 48.39% 47.24% 45.84% 55.86% 49.96% 45.61% 46.36% 48.49% 47.81%
SG&A Expenses to Revenue
14.41% 11.98% 10.57% 10.93% 12.31% 17.33% 11.74% 8.61% 6.92% 10.19% 8.69%
R&D to Revenue
20.29% 17.45% 14.22% 14.78% 14.59% 15.81% 15.20% 12.18% 11.14% 12.80% 11.83%
Operating Expenses to Revenue
52.56% 45.20% 38.45% 29.52% 35.50% 45.79% 45.24% 34.56% 30.09% 37.28% 33.24%
Earnings before Interest and Taxes (EBIT)
-11 5.79 29 59 51 -4.26 -29 155 237 112 187
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1.51 15 38 65 58 28 49 221 301 179 249
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.23 2.04 2.56 2.43 1.83 1.45 1.85 3.50 2.11 4.32 4.38
Price to Tangible Book Value (P/TBV)
2.43 2.17 2.66 2.55 1.99 3.13 3.67 5.99 3.19 5.99 5.74
Price to Revenue (P/Rev)
2.41 2.04 2.82 2.50 2.42 5.98 4.21 6.32 3.35 9.20 8.54
Price to Earnings (P/E)
0.00 131.47 14.18 19.38 14.68 957.73 75.58 35.04 15.10 61.94 41.80
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.76% 7.05% 5.16% 6.81% 0.10% 1.32% 2.85% 6.62% 1.61% 2.39%
Enterprise Value to Invested Capital (EV/IC)
3.31 2.87 4.34 3.58 2.61 1.60 2.21 4.89 2.69 6.55 7.06
Enterprise Value to Revenue (EV/Rev)
1.90 1.60 2.24 2.04 1.78 4.93 3.54 5.68 2.81 8.34 7.67
Enterprise Value to EBITDA (EV/EBITDA)
0.00 20.11 13.12 8.04 8.46 54.84 40.33 20.28 9.37 37.93 30.40
Enterprise Value to EBIT (EV/EBIT)
0.00 51.65 16.83 8.85 9.52 0.00 0.00 28.97 11.94 60.65 40.53
Enterprise Value to NOPAT (EV/NOPAT)
0.00 115.18 11.24 15.96 11.27 0.00 0.00 31.31 12.90 64.17 44.27
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 190.23 10.82 8.12 13.87 83.16 18.60 25.54 20.66 39.58 30.84
Enterprise Value to Free Cash Flow (EV/FCFF)
29.39 0.00 14.37 479.93 282.69 0.00 57.82 37.52 33.26 58.68 55.57
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.46 -0.46 -0.49 -0.49 -0.47 -0.30 -0.27 -0.33 -0.35 -0.37 -0.42
Leverage Ratio
1.26 1.25 1.21 1.18 1.17 1.15 1.15 1.16 1.14 1.11 1.10
Compound Leverage Factor
1.29 1.20 1.20 1.20 1.22 0.16 1.05 1.17 1.16 1.31 1.30
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
6.29 5.91 10.23 10.34 8.99 6.60 7.75 14.88 12.12 27.69 28.39
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.13 3.94 5.15 5.45 7.80 7.48 6.09 6.14 7.07 8.69 8.69
Quick Ratio
2.88 2.67 4.03 4.07 5.32 5.18 4.35 4.46 4.92 6.26 6.82
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
11 -6.07 34 1.09 1.72 -761 34 119 85 116 136
Operating Cash Flow to CapEx
-10.96% 85.10% 1,142.41% 628.51% 465.31% 266.77% 2,767.93% 1,455.94% 742.75% 869.74% 770.07%
Free Cash Flow to Firm to Interest Expense
27.71 -21.02 120.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-1.63 5.44 160.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-16.52 -0.95 146.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.68 0.82 0.85 0.85 0.75 0.33 0.38 0.51 0.58 0.44 0.49
Accounts Receivable Turnover
5.78 5.86 5.72 5.01 4.32 3.26 4.08 4.83 4.80 3.49 3.69
Inventory Turnover
2.31 2.23 2.33 2.52 1.66 1.25 1.51 1.66 1.64 1.21 1.54
Fixed Asset Turnover
3.43 3.98 4.98 5.73 8.60 5.22 5.97 9.28 11.55 8.34 8.68
Accounts Payable Turnover
8.71 8.93 9.30 9.56 8.14 7.64 8.19 7.69 8.64 7.58 8.90
Days Sales Outstanding (DSO)
63.11 62.29 63.79 72.91 84.42 112.07 89.50 75.52 76.00 104.68 98.84
Days Inventory Outstanding (DIO)
157.96 163.67 156.74 144.92 219.88 291.54 241.12 220.29 222.23 300.80 237.69
Days Payable Outstanding (DPO)
41.89 40.86 39.26 38.16 44.84 47.76 44.58 47.44 42.25 48.16 41.03
Cash Conversion Cycle (CCC)
179.18 185.11 181.27 179.67 259.47 355.85 286.04 248.38 255.98 357.32 295.49
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
96 104 114 145 187 944 891 915 1,049 1,039 1,074
Invested Capital Turnover
1.58 1.88 2.03 1.97 1.65 0.54 0.61 0.87 1.02 0.78 0.93
Increase / (Decrease) in Invested Capital
-19 8.67 9.57 32 41 757 -53 24 134 -9.92 35
Enterprise Value (EV)
317 299 494 521 487 1,509 1,971 4,477 2,824 6,807 7,577
Market Capitalization
401 382 624 638 662 1,829 2,345 4,988 3,372 7,504 8,429
Book Value per Share
$7.43 $7.74 $9.78 $10.25 $14.94 $25.25 $25.90 $28.94 $32.24 $35.38 $38.99
Tangible Book Value per Share
$6.82 $7.28 $9.41 $9.77 $13.71 $11.68 $13.10 $16.90 $21.37 $25.54 $29.73
Total Capital
180 187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-84 -83 -130 -117 -175 -320 -374 -511 -548 -698 -852
Capital Expenditures (CapEx)
5.79 1.85 4.00 10 7.54 6.80 3.83 12 18 20 32
Debt-free, Cash-free Net Working Capital (DFCFNWC)
36 50 44 79 131 236 238 282 427 438 455
Debt-free Net Working Capital (DFNWC)
120 133 174 196 306 556 612 794 974 1,136 1,307
Net Working Capital (NWC)
120 133 174 196 306 556 612 794 974 1,136 1,307
Net Nonoperating Expense (NNE)
23 -0.31 -0.06 -0.28 -1.91 -5.44 -50 0.66 -4.50 -15 -31
Net Nonoperating Obligations (NNO)
-84 -83 -130 -117 -175 -320 -374 -511 -548 -698 -852
Total Depreciation and Amortization (D&A)
9.77 9.08 8.30 5.93 6.38 32 78 66 65 67 62
Debt-free, Cash-free Net Working Capital to Revenue
21.44% 26.59% 20.08% 30.96% 47.79% 77.05% 42.74% 35.77% 42.43% 53.65% 46.09%
Debt-free Net Working Capital to Revenue
71.88% 70.93% 78.85% 76.84% 111.74% 181.74% 109.90% 100.59% 96.93% 139.18% 132.42%
Net Working Capital to Revenue
71.88% 70.93% 78.85% 76.84% 111.74% 181.74% 109.90% 100.59% 96.93% 139.18% 132.42%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.30) $0.12 $1.79 $1.19 $2.39 $0.06 $0.63 $2.89 $0.00 $2.47 $4.09
Adjusted Weighted Average Basic Shares Outstanding
23.96M 24.06M 24.66M 25.33M 24.12M 29.73M 49.14M 49.24M 0.00 48.97M 49.34M
Adjusted Diluted Earnings per Share
($1.30) $0.12 $1.75 $1.17 $2.34 $0.06 $0.63 $2.86 $0.00 $2.46 $4.06
Adjusted Weighted Average Diluted Shares Outstanding
23.96M 24.38M 25.15M 25.92M 24.60M 30.01M 49.48M 49.73M 0.00 49.32M 49.66M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
23.85M 24.30M 25.16M 23.76M 24.46M 50.28M 48.88M 49.36M 0.00 49.13M 49.27M
Normalized Net Operating Profit after Tax (NOPAT)
-6.57 3.31 20 25 43 -3.53 -19 143 219 106 171
Normalized NOPAT Margin
-3.95% 1.77% 9.21% 9.99% 15.77% -1.15% -3.36% 18.13% 21.77% 13.00% 17.34%
Pre Tax Income Margin
-6.98% 2.97% 13.18% 23.44% 19.48% -0.20% -4.83% 19.73% 24.03% 16.25% 22.33%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-28.99 20.02 103.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-20.97 8.98 154.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-43.88 13.63 89.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-35.86 2.59 140.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-1.89% 29.29% 0.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-19.06% 88.54% 0.72% 3.11% 46.72% 38.95% 167.61% 0.00% 29.22% 2.64% 12.43%

Quarterly Metrics And Ratios for Onto Innovation

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 49,702,361.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 49,702,361.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.68
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-25.61% -18.51% -13.59% 14.90% 27.10% 21.73% 20.60% 16.50% 4.65% -13.49% 9.51%
EBITDA Growth
-45.23% -32.83% -44.41% 31.95% 64.28% 38.63% 23.52% 26.09% -30.94% -48.38% -21.02%
EBIT Growth
-59.19% -43.43% -56.62% 51.39% 111.17% 58.61% 54.57% 43.33% -36.21% -56.66% -47.19%
NOPAT Growth
-55.44% -39.04% -59.09% 50.12% 95.77% 46.33% 59.83% 43.52% -39.05% -54.69% -47.36%
Net Income Growth
-49.79% -31.27% -54.23% 61.18% 104.47% 47.83% 61.06% 36.80% -35.96% -46.80% -47.34%
EPS Growth
-48.54% -30.48% -54.48% 59.32% 101.89% 46.58% 60.66% 38.30% -35.51% -46.73% -48.46%
Operating Cash Flow Growth
219.05% -10.02% 24.43% 14.11% 106.07% 134.87% -9.07% 61.00% -11.27% 24.01% -71.38%
Free Cash Flow Firm Growth
-229.75% 65.46% 148.84% 147.15% 213.41% 452.82% -84.10% -29.50% -89.64% -21.10% -1,450.72%
Invested Capital Growth
6.53% 4.90% -0.95% -0.05% -0.14% -1.72% 3.35% 2.73% 2.17% -2.86% 38.26%
Revenue Q/Q Growth
-4.27% 8.67% 5.63% 4.56% 5.89% 4.08% 4.65% 1.01% -4.88% -13.96% 0.00%
EBITDA Q/Q Growth
-12.47% 25.64% -11.87% 36.15% 8.97% 6.02% -21.48% 35.32% -40.42% -20.72% 0.00%
EBIT Q/Q Growth
-19.67% 42.90% -17.07% 59.05% 12.04% 7.33% -19.18% 47.48% -50.14% -27.07% 0.00%
NOPAT Q/Q Growth
-12.01% 36.73% -19.79% 55.55% 14.75% 2.20% -12.39% 39.68% -51.27% -24.02% 0.00%
Net Income Q/Q Growth
-10.91% 38.58% -15.54% 54.58% 13.01% 0.19% -7.98% 31.30% -47.09% -16.77% 0.00%
EPS Q/Q Growth
-10.17% 37.74% -16.44% 54.10% 13.83% 0.00% -8.41% 32.65% -46.92% -17.39% 0.00%
Operating Cash Flow Q/Q Growth
-36.71% -9.64% 115.10% -7.23% 14.30% 2.98% -16.73% 64.25% -37.00% 43.93% 0.00%
Free Cash Flow Firm Q/Q Growth
51.35% 55.52% 292.61% 13.12% 17.03% 38.37% -91.32% 401.64% -82.80% 953.53% 0.00%
Invested Capital Q/Q Growth
0.58% 1.85% -2.60% 0.18% 0.48% 0.24% 2.43% -0.42% -0.06% -4.70% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.69% 51.57% 49.33% 51.69% 52.92% 54.07% 50.17% 53.72% 48.16% 50.70% 50.14%
EBITDA Margin
20.89% 24.15% 20.15% 26.23% 27.00% 27.50% 20.63% 27.64% 17.31% 15.95% 19.94%
Operating Margin
13.01% 16.41% 12.90% 18.68% 20.15% 21.04% 16.09% 23.68% 12.72% 10.86% 11.48%
EBIT Margin
12.11% 15.93% 12.51% 19.02% 20.13% 20.76% 16.03% 23.40% 12.27% 10.40% 11.29%
Profit (Net Income) Margin
13.58% 17.32% 13.85% 20.47% 21.85% 21.03% 18.50% 24.04% 13.37% 12.94% 11.56%
Tax Burden Percent
92.97% 92.73% 89.60% 92.06% 92.46% 86.95% 95.21% 89.45% 85.33% 88.26% 88.69%
Interest Burden Percent
120.60% 117.25% 123.59% 116.91% 117.42% 116.56% 121.19% 114.85% 127.74% 140.95% 115.48%
Effective Tax Rate
7.03% 7.27% 10.40% 7.94% 7.54% 13.05% 4.79% 10.55% 14.67% 11.74% 11.31%
Return on Invested Capital (ROIC)
10.69% 12.43% 9.03% 13.97% 15.98% 16.31% 14.32% 20.58% 10.64% 9.30% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
10.20% 11.69% 8.23% 12.83% 14.86% 15.38% 13.24% 19.63% 9.88% 8.50% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-3.70% -4.23% -3.08% -4.99% -5.94% -6.34% -5.60% -8.44% -4.38% -4.00% 0.00%
Return on Equity (ROE)
6.99% 8.19% 5.96% 8.98% 10.03% 9.96% 8.72% 12.14% 6.26% 5.29% 0.00%
Cash Return on Invested Capital (CROIC)
9.74% 8.90% 11.11% 11.50% 13.64% 16.49% 12.91% 15.16% 13.99% 16.96% -32.12%
Operating Return on Assets (OROA)
6.07% 7.42% 5.51% 8.56% 9.44% 9.94% 7.86% 11.79% 6.13% 4.89% 0.00%
Return on Assets (ROA)
6.80% 8.07% 6.10% 9.22% 10.25% 10.07% 9.07% 12.11% 6.69% 6.09% 0.00%
Return on Common Equity (ROCE)
6.99% 8.19% 5.96% 8.98% 10.03% 9.96% 8.72% 12.14% 6.26% 5.29% 0.00%
Return on Equity Simple (ROE_SIMPLE)
10.47% 9.26% 0.00% 7.80% 9.06% 9.62% 0.00% 11.40% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
23 32 25 39 45 46 40 56 28 21 30
NOPAT Margin
12.10% 15.22% 11.56% 17.19% 18.63% 18.30% 15.32% 21.18% 10.85% 9.58% 10.18%
Net Nonoperating Expense Percent (NNEP)
0.49% 0.74% 0.81% 1.13% 1.12% 0.93% 1.08% 0.96% 0.76% 0.80% 0.54%
Return On Investment Capital (ROIC_SIMPLE)
- - 1.46% - - - 2.10% 2.94% 1.40% 1.04% 1.39%
Cost of Revenue to Revenue
47.31% 48.43% 50.67% 48.31% 47.08% 45.93% 49.83% 46.28% 54.30% 51.17% 51.64%
SG&A Expenses to Revenue
9.84% 8.75% 12.34% 7.67% 8.37% 8.91% 9.68% 8.97% 9.86% 11.38% 10.76%
R&D to Revenue
14.18% 12.61% 10.98% 11.60% 11.16% 11.21% 13.22% 10.51% 13.92% 14.89% 12.02%
Operating Expenses to Revenue
39.68% 35.16% 36.43% 33.01% 32.77% 33.03% 34.08% 30.04% 32.99% 37.98% 36.88%
Earnings before Interest and Taxes (EBIT)
23 33 27 44 49 52 42 62 31 23 33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
40 50 44 60 65 69 54 74 44 35 58
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.44 3.69 4.32 4.99 5.91 5.59 4.38 3.13 2.46 3.12 4.78
Price to Tangible Book Value (P/TBV)
4.97 5.22 5.99 6.78 7.87 7.29 5.74 4.09 3.17 3.98 8.42
Price to Revenue (P/Rev)
6.35 7.36 9.20 10.51 12.06 11.29 8.54 5.87 4.66 6.24 0.00
Price to Earnings (P/E)
32.88 39.84 61.94 63.97 65.18 58.07 41.80 27.47 24.18 35.72 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.04% 2.51% 1.61% 1.56% 1.53% 1.72% 2.39% 3.64% 4.14% 2.80% 0.00%
Enterprise Value to Invested Capital (EV/IC)
4.86 5.28 6.55 7.83 9.60 9.33 7.06 4.83 3.69 5.17 6.45
Enterprise Value to Revenue (EV/Rev)
5.67 6.62 8.34 9.63 11.18 10.38 7.67 5.04 3.80 5.26 0.00
Enterprise Value to EBITDA (EV/EBITDA)
21.29 26.21 37.93 42.00 45.69 40.94 30.40 19.52 16.08 24.82 0.00
Enterprise Value to EBIT (EV/EBIT)
29.38 38.03 60.65 64.15 65.71 56.86 40.53 25.09 20.93 33.24 0.00
Enterprise Value to NOPAT (EV/NOPAT)
31.23 39.49 64.17 68.34 71.00 62.70 44.27 27.42 23.08 36.26 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
31.22 35.20 39.58 45.50 47.18 38.92 30.84 18.41 14.42 18.21 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
51.51 60.72 58.68 68.06 70.27 56.10 55.57 32.29 26.62 30.06 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.36 -0.36 -0.37 -0.39 -0.40 -0.41 -0.42 -0.43 -0.44 -0.47 -0.37
Leverage Ratio
1.12 1.12 1.11 1.10 1.10 1.09 1.10 1.10 1.09 1.09 1.11
Compound Leverage Factor
1.36 1.31 1.37 1.29 1.29 1.27 1.33 1.26 1.40 1.54 1.29
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
22.38 24.16 27.54 32.65 39.04 39.30 28.16 20.23 18.13 22.05 24.20
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.64 9.00 8.69 9.06 9.33 10.07 8.69 8.42 9.59 9.49 6.15
Quick Ratio
5.82 6.18 6.26 6.62 6.90 7.66 6.82 6.55 7.58 7.64 4.48
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-41 -18 35 40 47 65 5.60 28 4.83 51 -379
Operating Cash Flow to CapEx
687.67% 374.42% 2,500.45% 819.08% 532.92% 835.47% 1,210.53% 1,117.21% 420.73% 6,047.57% 734.23%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.50 0.47 0.44 0.45 0.47 0.48 0.49 0.50 0.50 0.47 0.00
Accounts Receivable Turnover
4.25 3.82 3.49 3.83 4.22 4.07 3.69 3.92 3.96 3.90 0.00
Inventory Turnover
1.31 1.23 1.21 1.23 1.30 1.38 1.54 1.56 1.72 1.77 0.00
Fixed Asset Turnover
9.81 9.02 8.34 8.27 8.33 8.40 8.68 8.76 8.34 8.05 0.00
Accounts Payable Turnover
6.83 7.39 7.58 7.52 8.63 9.76 8.90 8.71 11.40 9.95 0.00
Days Sales Outstanding (DSO)
85.94 95.52 104.68 95.29 86.59 89.72 98.84 93.19 92.13 93.57 0.00
Days Inventory Outstanding (DIO)
277.67 297.78 300.80 295.85 281.28 264.57 237.69 234.20 211.75 206.34 0.00
Days Payable Outstanding (DPO)
53.48 49.37 48.16 48.55 42.28 37.38 41.03 41.89 32.03 36.68 0.00
Cash Conversion Cycle (CCC)
310.13 343.93 357.32 342.59 325.58 316.91 295.49 285.51 271.85 263.23 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,047 1,066 1,039 1,041 1,046 1,048 1,074 1,069 1,068 1,018 1,478
Invested Capital Turnover
0.88 0.82 0.78 0.81 0.86 0.89 0.93 0.97 0.98 0.97 0.00
Increase / (Decrease) in Invested Capital
64 50 -9.92 -0.49 -1.47 -18 35 28 23 -30 409
Enterprise Value (EV)
5,091 5,627 6,807 8,147 10,033 9,780 7,577 5,164 3,938 5,268 9,538
Market Capitalization
5,701 6,257 7,504 8,888 10,819 10,636 8,429 6,014 4,833 6,252 10,192
Book Value per Share
$33.85 $34.57 $35.38 $36.19 $37.17 $38.55 $38.99 $38.96 $40.17 $40.86 $42.90
Tangible Book Value per Share
$23.42 $24.45 $25.54 $26.64 $27.90 $29.56 $29.73 $29.85 $31.15 $32.04 $24.35
Total Capital
1,657 1,696 1,737 1,782 1,832 1,904 1,926 1,920 1,963 2,002 2,132
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-610 -630 -698 -741 -786 -855 -852 -851 -895 -984 -654
Capital Expenditures (CapEx)
4.61 7.65 2.46 6.98 12 8.05 4.63 8.23 14 1.38 3.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)
437 456 438 445 451 458 455 444 444 398 451
Debt-free Net Working Capital (DFNWC)
1,046 1,085 1,136 1,186 1,237 1,313 1,307 1,295 1,339 1,382 1,105
Net Working Capital (NWC)
1,046 1,085 1,136 1,186 1,237 1,313 1,307 1,295 1,339 1,382 1,105
Net Nonoperating Expense (NNE)
-2.83 -4.35 -5.01 -7.51 -7.80 -6.91 -8.39 -7.62 -6.39 -7.32 -4.02
Net Nonoperating Obligations (NNO)
-610 -630 -698 -741 -786 -855 -852 -851 -895 -984 -654
Total Depreciation and Amortization (D&A)
17 17 17 17 17 17 12 11 13 12 25
Debt-free, Cash-free Net Working Capital to Revenue
48.64% 53.60% 53.65% 52.61% 50.24% 48.59% 46.09% 43.33% 42.81% 39.72% 0.00%
Debt-free Net Working Capital to Revenue
116.58% 127.66% 139.18% 140.24% 137.85% 139.37% 132.42% 126.31% 129.17% 137.88% 0.00%
Net Working Capital to Revenue
116.58% 127.66% 139.18% 140.24% 137.85% 139.37% 132.42% 126.31% 129.17% 137.88% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.53 $0.73 $0.61 $0.95 $1.07 $1.07 $1.00 $1.30 $0.69 $0.58 $0.68
Adjusted Weighted Average Basic Shares Outstanding
48.98M 49.04M 48.97M 49.23M 49.34M 49.43M 49.34M 49.18M 48.93M 49.02M 49.74M
Adjusted Diluted Earnings per Share
$0.53 $0.73 $0.61 $0.94 $1.07 $1.07 $0.98 $1.30 $0.69 $0.57 $0.67
Adjusted Weighted Average Diluted Shares Outstanding
49.27M 49.40M 49.32M 49.64M 49.67M 49.69M 49.66M 49.41M 49.02M 49.11M 50.00M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
49.07M 49.08M 49.13M 49.28M 49.38M 49.39M 49.27M 48.87M 49.00M 49.01M 49.74M
Normalized Net Operating Profit after Tax (NOPAT)
23 32 25 39 45 46 40 56 28 21 30
Normalized NOPAT Margin
12.10% 15.22% 11.56% 17.19% 18.63% 18.30% 15.32% 21.18% 10.85% 9.58% 10.18%
Pre Tax Income Margin
14.61% 18.68% 15.46% 22.24% 23.63% 24.19% 19.43% 26.88% 15.67% 14.66% 13.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
39.48% 36.24% 2.64% 0.00% 0.00% 0.00% 12.43% 45.72% 50.07% 57.18% 0.00%

Financials Breakdown Chart

Key Financial Trends

Onto Innovation (NYSE:ONTO) has shown earnings profitability and solid liquidity across the last four years of quarterly results. Below is a concise, investor-focused trend snapshot drawn from the quarterly statements provided, with quick takeaways you can use when evaluating the stock.

  • Strong liquidity: as of Q1 2026, Total Current Assets are about $1.320B vs. Total Current Liabilities of about $214.4M, yielding a current ratio around 6x. The company also holds cash and short-term investments totaling roughly $654M, which provides a sizable cushion against near-term volatility.
  • Healthy operating cash flow: quarterly cash from continuing operating activities has remained positive in the shown periods, reflecting cash generation from core operations. Notably, quarterly figures range roughly from $26M up to the low-$90Ms in earlier quarters, signaling robust cash production over time.
  • Stable gross margins: gross margin sits around the 50% level across periods (example: Q1 2026 gross margin about 50%), indicating a durable cost structure relative to revenue.
  • Tax and leverage posture: total liabilities are modest relative to equity (Total Equity around $2.13B vs. Total Liabilities around $264M in Q1 2026), suggesting low leverage and a strong balance sheet relative to peers in the sector.
  • Capital returns and selective liquidity management: there are periods of equity repurchases and modest issuances, which can support EPS for shareholders over time while maintaining a solid balance sheet. For example, equity activity has included both repurchases and small issuances in different quarters.
  • Revenue volatility: quarterly revenue has fluctuated (e.g., Q3 2025 revenue around $218.2M vs. higher levels in other quarters), indicating cyclicality in demand or mix that may impact quarter-to-quarter comparisons and near-term guidance.
  • Non-cash adjustments dominate some profit measures: depreciation and amortization are consistently large, contributing to non-cash adjustments that can obscure cash-based profitability in headline net income figures.
  • Earnings per share can move with share count: weighted-average shares outstanding have varied (roughly mid- to high-40s millions across periods), so EPS may swing due to changes in shares outstanding even when net income is steady.
  • Investing cash outflows can be meaningful in some quarters: several periods show sizable cash outlays for investing activities, which pressures free cash flow during those quarters (e.g., notable investing outflows in certain Q2/Q3 periods).
  • Revenue cyclicality risk remains visible: the notable mid-year revenue dip (e.g., in some quarters like Q3 2025) highlights cyclicality that could weigh on near-term profitability if demand softens further.
05/14/26 01:52 AM ETAI Generated. May Contain Errors.

Onto Innovation Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Onto Innovation's financial year ends in December. Their financial year 2024 ended on December 28, 2024.

Onto Innovation's net income appears to be on an upward trend, with a most recent value of $201.67 million in 2024, falling from -$31.12 million in 2014. The previous period was $121.16 million in 2023. See Onto Innovation's forecast for analyst expectations on what's next for the company.

Onto Innovation's total operating income in 2024 was $187.10 million, based on the following breakdown:
  • Total Gross Profit: $515.31 million
  • Total Operating Expenses: $328.21 million

Over the last 10 years, Onto Innovation's total revenue changed from $166.44 million in 2014 to $987.32 million in 2024, a change of 493.2%.

Onto Innovation's total liabilities were at $267.09 million at the end of 2025, a 39.7% increase from 2024, and a 454.0% increase since 2015.

In the past 10 years, Onto Innovation's cash and equivalents has ranged from $34.90 million in 2017 to $346.12 million in 2025, and is currently $346.12 million as of their latest financial filing in 2025.

Over the last 10 years, Onto Innovation's book value per share changed from 7.43 in 2014 to 38.99 in 2024, a change of 424.7%.



Financial statements for NYSE:ONTO last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners